|
27.05.25 - 23:03
|
embecta to Participate in Investor Events (GlobeNewswire EN)
|
|
PARSIPPANY, N.J., May 27, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, today announced that management will participate in the following investor events:...
|
|
26.05.25 - 23:51
|
XFRA: DIVIDEND/INTEREST INFORMATION - 28.05.2025 - EQUBF_01 (XETRA)
|
|
Das Instrument JX7 US29082K1051 EMBECTA CORP. DL-,01 EQUITY wird cum Dividende/Zinsen gehandelt am 27.05.2025 und ex Dividende/Zinsen am 28.05.2025
The instrument JX7 US29082K1051 EMBECTA CORP. DL-,01 EQUITY has its pre-dividend/interest day on 27.05.2025 and its ex-dividend/interest day on 28.05.2025...
|
|
|
|
|
|
|
|
|
|
09.05.25 - 12:03
|
embecta Announces Quarterly Cash Dividend (GlobeNewswire EN)
|
|
PARSIPPANY, N.J., May 09, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstanding share of the Company's common stock. The dividend is payable on June 13, 2025 to stockholders of record at the close of business on May 28, 2025....
|
|
|
21.04.25 - 23:03
|
embecta to Report Fiscal Second Quarter 2025 Financial Results (GlobeNewswire EN)
|
|
PARSIPPANY, N.J., April 21, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its fiscal second quarter 2025 financial results, provide an operational update, and host a question and answer session, at 8:00 a.m. Eastern Time (ET) on Friday, May 9, 2025....
|
|
|
|
|
|
|
|
|